<p>PBS was used as the control. (A) The titers of IgG specific to MERS-CoV S377-588-Fc (S-RBD) in sera (1:3,200 dilution) of mice at pre-immunization (pre-immune) and 10 days post-each vaccination. (B) Endpoint IgG titers in mouse sera from 10 days post-last vaccination. The data are presented as mean A450 ± standard deviation (SD) of five mice per group. Ability of IgG binding to MERS-CoV S-RBD (C) and S1 protein (D) was detected using mouse sera from 10 days post-last vaccination. Ability of IgG1 (E) and IgG2a (F) antibodies binding to MERS-CoV S-RBD was detected using sera from 10 days post-last vaccination. The data are presented as mean A450 ± SD of five mice per group at various dilution points.</p
<p>Mice received PBS serve as control group. Sera and saliva were collected on day 14 after last imm...
<p>Groups of BALB/c mice (n=5) were vaccinated with nanoparticle vaccines diluted in PBS to yield 50...
(a) Schematic flow chart of the immunization experiment. Reciprocal anti-RBD (b) total IgG, (c) IgG1...
<p>PBS was used as the negative control. (A) Reactivity of IgG antibody with HA1-Fc and HA1-Fdc prot...
<p>PBS was used as the negative control. Ability of IgG1 (A) and IgG2a (B) antibodies binds to the H...
<p>(A) Sera collected at 10 days post-last vaccination were tested for neutralization of MERS-CoV in...
<p>PBS was used as the negative control. Ability of IgG binding to HA1 (HA-13–263-His) protein (A) a...
<p>A) Total RBD-specific IgG titres were determined by ELISA 2 weeks after the second and third immu...
RSV F and G protein specific IgG antibodies were determined by ELISA in sera collected at 3 weeks af...
IgG (A) and IgA (B) antibody levels in serum were detected 7 days after the last immunization from t...
<p>Mice were vaccinated twice with RSV virosomes, RSV-MPLA virosomes or controls (HNE, live virus an...
<p>Mouse sera (8 per group) were collected 10 days after the final immunization and assayed for IgG1...
<p>[A] Sera collected after first booster (14<sup>th</sup> day) and second boosters (21<sup>st</sup>...
<p>Mice were administered PBS (Control), ITIV (0.5 μg A/H1N, A/H3N2, and B HA/mouse; Vaccine), ITIV ...
<p>At 90 days post-immunization, mice were challenged with 10<sup>4</sup> PFUs of FMDV C-S8c1 (proce...
<p>Mice received PBS serve as control group. Sera and saliva were collected on day 14 after last imm...
<p>Groups of BALB/c mice (n=5) were vaccinated with nanoparticle vaccines diluted in PBS to yield 50...
(a) Schematic flow chart of the immunization experiment. Reciprocal anti-RBD (b) total IgG, (c) IgG1...
<p>PBS was used as the negative control. (A) Reactivity of IgG antibody with HA1-Fc and HA1-Fdc prot...
<p>PBS was used as the negative control. Ability of IgG1 (A) and IgG2a (B) antibodies binds to the H...
<p>(A) Sera collected at 10 days post-last vaccination were tested for neutralization of MERS-CoV in...
<p>PBS was used as the negative control. Ability of IgG binding to HA1 (HA-13–263-His) protein (A) a...
<p>A) Total RBD-specific IgG titres were determined by ELISA 2 weeks after the second and third immu...
RSV F and G protein specific IgG antibodies were determined by ELISA in sera collected at 3 weeks af...
IgG (A) and IgA (B) antibody levels in serum were detected 7 days after the last immunization from t...
<p>Mice were vaccinated twice with RSV virosomes, RSV-MPLA virosomes or controls (HNE, live virus an...
<p>Mouse sera (8 per group) were collected 10 days after the final immunization and assayed for IgG1...
<p>[A] Sera collected after first booster (14<sup>th</sup> day) and second boosters (21<sup>st</sup>...
<p>Mice were administered PBS (Control), ITIV (0.5 μg A/H1N, A/H3N2, and B HA/mouse; Vaccine), ITIV ...
<p>At 90 days post-immunization, mice were challenged with 10<sup>4</sup> PFUs of FMDV C-S8c1 (proce...
<p>Mice received PBS serve as control group. Sera and saliva were collected on day 14 after last imm...
<p>Groups of BALB/c mice (n=5) were vaccinated with nanoparticle vaccines diluted in PBS to yield 50...
(a) Schematic flow chart of the immunization experiment. Reciprocal anti-RBD (b) total IgG, (c) IgG1...